# Department of Defense - Army – FDA Inspection, Mar 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/department-of-defense-army/53083a71-fccd-487a-97cb-78fc0140e1cb
Source feed: FDA_Inspections

> FDA inspection 1006805 of Department of Defense - Army, March 15, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1006805
- Company Name: Department of Defense - Army
- Inspection Date: 2017-03-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1255732 - 2024-11-12
- FDA Inspection 1091692 - 2019-05-15
- FDA Inspection 915802 - 2015-02-24
- FDA Inspection 820252 - 2013-02-26
- [FDA Inspection 721822 - 2011-04-22](https://www.keypedia.com/records/fda_inspections/department-of-defense-army/d399a7bf-fc3a-40f1-862e-b2510b77c64e)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/peter-s-kessler/f3a9dea7-3a2d-4c86-9ec6-97791f9b6c21)

Company: https://www.keypedia.com/companies/department-of-defense-army/c187bf85-3694-4fe4-9f41-b97caf415f74

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d